Cargando…
Adherence and feasibility of 2 treatment schedules of S-1 as adjuvant chemotherapy for patients with completely resected advanced lung cancer: a multicenter randomized controlled trial
BACKGROUND: We conducted a multicenter randomized study of adjuvant S-1 administration schedules for surgically treated pathological stage IB-IIIA non-small cell lung cancer patients. METHODS: Patients receiving curative surgical resection were centrally randomized to arm A (4 weeks of oral S-1 and...
Autores principales: | Hata, Yoshinobu, Kiribayashi, Takaharu, Kishi, Kazuma, Nagashima, Makoto, Nakayama, Takefumi, Ikeda, Shingo, Kadokura, Mitsutaka, Ozeki, Yuichi, Otsuka, Hajime, Murakami, Yoshitaka, Takagi, Keigo, Iyoda, Akira |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5575891/ https://www.ncbi.nlm.nih.gov/pubmed/28851314 http://dx.doi.org/10.1186/s12885-017-3584-y |
Ejemplares similares
-
Acceptability and feasibility of S-1 plus cisplatin adjuvant chemotherapy for completely resected non-small cell lung cancer: an open-label, single arm, multicenter, phase 2 trial
por: Uematsu, Shugo, et al.
Publicado: (2021) -
Treatment options for patients with large cell neuroendocrine carcinoma of the lung
por: Iyoda, Akira, et al.
Publicado: (2014) -
Preoperative undernutrition predicts postoperative complications of acute empyema
por: Sakai, Takashi, et al.
Publicado: (2021) -
Primary extranodal marginal zone lymphoma of mucosa-associated lymphoid tissue with multiple pure ground-glass opacities: a case report
por: Ding, Xuebing, et al.
Publicado: (2017) -
Impact of accurate diagnosis of interstitial lung diseases on postoperative outcomes in lung cancer
por: Azuma, Yoko, et al.
Publicado: (2022)